Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral
1.2.3 Inhalation
1.2.4 Others
1.3 Market by Application
1.3.1 Global Endocannabinoid System Targeted Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Autoimmune Disorders
1.3.3 Genetic Disorders
1.3.4 Neurological Disorders
1.3.5 Pain Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocannabinoid System Targeted Therapeutics Market Perspective (2018-2033)
2.2 Endocannabinoid System Targeted Therapeutics Growth Trends by Region
2.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Endocannabinoid System Targeted Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Endocannabinoid System Targeted Therapeutics Market Dynamics
2.3.1 Endocannabinoid System Targeted Therapeutics Industry Trends
2.3.2 Endocannabinoid System Targeted Therapeutics Market Drivers
2.3.3 Endocannabinoid System Targeted Therapeutics Market Challenges
2.3.4 Endocannabinoid System Targeted Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue
3.1.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endocannabinoid System Targeted Therapeutics Revenue
3.4 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio
3.4.1 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocannabinoid System Targeted Therapeutics Revenue in 2022
3.5 Endocannabinoid System Targeted Therapeutics Key Players Head office and Area Served
3.6 Key Players Endocannabinoid System Targeted Therapeutics Product Solution and Service
3.7 Date of Enter into Endocannabinoid System Targeted Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocannabinoid System Targeted Therapeutics Breakdown Data by Type
4.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2024-2033)
5 Endocannabinoid System Targeted Therapeutics Breakdown Data by Application
5.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Endocannabinoid System Targeted Therapeutics Market Size (2018-2033)
6.2 North America Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023)
6.4 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocannabinoid System Targeted Therapeutics Market Size (2018-2033)
7.2 Europe Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023)
7.4 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size (2018-2033)
9.2 Latin America Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GW Pharmaceuticals
11.1.1 GW Pharmaceuticals Company Detail
11.1.2 GW Pharmaceuticals Business Overview
11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.1.4 GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.1.5 GW Pharmaceuticals Recent Development
11.2 MAKScientific
11.2.1 MAKScientific Company Detail
11.2.2 MAKScientific Business Overview
11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Introduction
11.2.4 MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.2.5 MAKScientific Recent Development
11.3 Corbus Pharmaceuticals
11.3.1 Corbus Pharmaceuticals Company Detail
11.3.2 Corbus Pharmaceuticals Business Overview
11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.3.4 Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.3.5 Corbus Pharmaceuticals Recent Development
11.4 Tilray
11.4.1 Tilray Company Detail
11.4.2 Tilray Business Overview
11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Introduction
11.4.4 Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.4.5 Tilray Recent Development
11.5 Pure Green
11.5.1 Pure Green Company Detail
11.5.2 Pure Green Business Overview
11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Introduction
11.5.4 Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.5.5 Pure Green Recent Development
11.6 Avicanna
11.6.1 Avicanna Company Detail
11.6.2 Avicanna Business Overview
11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Introduction
11.6.4 Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.6.5 Avicanna Recent Development
11.7 GB Sciences
11.7.1 GB Sciences Company Detail
11.7.2 GB Sciences Business Overview
11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Introduction
11.7.4 GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.7.5 GB Sciences Recent Development
11.8 Botanix Pharmaceuticals
11.8.1 Botanix Pharmaceuticals Company Detail
11.8.2 Botanix Pharmaceuticals Business Overview
11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.8.4 Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.8.5 Botanix Pharmaceuticals Recent Development
11.9 Therapix Biosciences
11.9.1 Therapix Biosciences Company Detail
11.9.2 Therapix Biosciences Business Overview
11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Introduction
11.9.4 Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.9.5 Therapix Biosciences Recent Development
11.10 Zelira Therapeutics
11.10.1 Zelira Therapeutics Company Detail
11.10.2 Zelira Therapeutics Business Overview
11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Introduction
11.10.4 Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
11.10.5 Zelira Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral
Table 3. Key Players of Inhalation
Table 4. Key Players of Others
Table 5. Global Endocannabinoid System Targeted Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Endocannabinoid System Targeted Therapeutics Market Share by Region (2018-2023)
Table 9. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Endocannabinoid System Targeted Therapeutics Market Share by Region (2024-2033)
Table 11. Endocannabinoid System Targeted Therapeutics Market Trends
Table 12. Endocannabinoid System Targeted Therapeutics Market Drivers
Table 13. Endocannabinoid System Targeted Therapeutics Market Challenges
Table 14. Endocannabinoid System Targeted Therapeutics Market Restraints
Table 15. Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2022)
Table 18. Ranking of Global Top Endocannabinoid System Targeted Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Endocannabinoid System Targeted Therapeutics Product Solution and Service
Table 22. Date of Enter into Endocannabinoid System Targeted Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2024-2033)
Table 32. North America Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. GW Pharmaceuticals Company Detail
Table 48. GW Pharmaceuticals Business Overview
Table 49. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 50. GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 51. GW Pharmaceuticals Recent Development
Table 52. MAKScientific Company Detail
Table 53. MAKScientific Business Overview
Table 54. MAKScientific Endocannabinoid System Targeted Therapeutics Product
Table 55. MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 56. MAKScientific Recent Development
Table 57. Corbus Pharmaceuticals Company Detail
Table 58. Corbus Pharmaceuticals Business Overview
Table 59. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 60. Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 61. Corbus Pharmaceuticals Recent Development
Table 62. Tilray Company Detail
Table 63. Tilray Business Overview
Table 64. Tilray Endocannabinoid System Targeted Therapeutics Product
Table 65. Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Tilray Recent Development
Table 67. Pure Green Company Detail
Table 68. Pure Green Business Overview
Table 69. Pure Green Endocannabinoid System Targeted Therapeutics Product
Table 70. Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Pure Green Recent Development
Table 72. Avicanna Company Detail
Table 73. Avicanna Business Overview
Table 74. Avicanna Endocannabinoid System Targeted Therapeutics Product
Table 75. Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 76. Avicanna Recent Development
Table 77. GB Sciences Company Detail
Table 78. GB Sciences Business Overview
Table 79. GB Sciences Endocannabinoid System Targeted Therapeutics Product
Table 80. GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 81. GB Sciences Recent Development
Table 82. Botanix Pharmaceuticals Company Detail
Table 83. Botanix Pharmaceuticals Business Overview
Table 84. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 85. Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 86. Botanix Pharmaceuticals Recent Development
Table 87. Therapix Biosciences Company Detail
Table 88. Therapix Biosciences Business Overview
Table 89. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product
Table 90. Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 91. Therapix Biosciences Recent Development
Table 92. Zelira Therapeutics Company Detail
Table 93. Zelira Therapeutics Business Overview
Table 94. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product
Table 95. Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2018-2023) & (US$ Million)
Table 96. Zelira Therapeutics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endocannabinoid System Targeted Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Endocannabinoid System Targeted Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Oral Features
Figure 4. Inhalation Features
Figure 5. Others Features
Figure 6. Global Endocannabinoid System Targeted Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Endocannabinoid System Targeted Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Autoimmune Disorders Case Studies
Figure 9. Genetic Disorders Case Studies
Figure 10. Neurological Disorders Case Studies
Figure 11. Pain Disorders Case Studies
Figure 12. Endocannabinoid System Targeted Therapeutics Report Years Considered
Figure 13. Global Endocannabinoid System Targeted Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Endocannabinoid System Targeted Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Endocannabinoid System Targeted Therapeutics Market Share by Region: 2022 VS 2033
Figure 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Players in 2022
Figure 17. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2022
Figure 19. North America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Endocannabinoid System Targeted Therapeutics Market Share by Country (2018-2033)
Figure 21. United States Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Endocannabinoid System Targeted Therapeutics Market Share by Country (2018-2033)
Figure 25. Germany Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Region (2018-2033)
Figure 33. China Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Country (2018-2033)
Figure 41. Mexico Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Country (2018-2033)
Figure 45. Turkey Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. GW Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 48. MAKScientific Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 49. Corbus Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 50. Tilray Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 51. Pure Green Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 52. Avicanna Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 53. GB Sciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 54. Botanix Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 55. Therapix Biosciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 56. Zelira Therapeutics Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed